|
US4447233A
(en)
|
1981-04-10 |
1984-05-08 |
Parker-Hannifin Corporation |
Medication infusion pump
|
|
US4439196A
(en)
|
1982-03-18 |
1984-03-27 |
Merck & Co., Inc. |
Osmotic drug delivery system
|
|
US4447224A
(en)
|
1982-09-20 |
1984-05-08 |
Infusaid Corporation |
Variable flow implantable infusion apparatus
|
|
US4487603A
(en)
|
1982-11-26 |
1984-12-11 |
Cordis Corporation |
Implantable microinfusion pump system
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US4596556A
(en)
|
1985-03-25 |
1986-06-24 |
Bioject, Inc. |
Hypodermic injection apparatus
|
|
AU584417B2
(en)
|
1985-04-01 |
1989-05-25 |
Lonza Group Ag |
Transformed myeloma cell-line and a process for the expression of a gene coding for a eukaryotic polypeptide employing same
|
|
GB8601597D0
(en)
|
1986-01-23 |
1986-02-26 |
Wilson R H |
Nucleotide sequences
|
|
US4790824A
(en)
|
1987-06-19 |
1988-12-13 |
Bioject, Inc. |
Non-invasive hypodermic injection device
|
|
US4941880A
(en)
|
1987-06-19 |
1990-07-17 |
Bioject, Inc. |
Pre-filled ampule and non-invasive hypodermic injection device assembly
|
|
GB8717430D0
(en)
|
1987-07-23 |
1987-08-26 |
Celltech Ltd |
Recombinant dna product
|
|
US5312335A
(en)
|
1989-11-09 |
1994-05-17 |
Bioject Inc. |
Needleless hypodermic injection device
|
|
US5064413A
(en)
|
1989-11-09 |
1991-11-12 |
Bioject, Inc. |
Needleless hypodermic injection device
|
|
US5383851A
(en)
|
1992-07-24 |
1995-01-24 |
Bioject Inc. |
Needleless hypodermic injection device
|
|
GB9818110D0
(en)
|
1998-08-19 |
1998-10-14 |
Weston Medical Ltd |
Needleless injectors and other devices
|
|
US6096002A
(en)
|
1998-11-18 |
2000-08-01 |
Bioject, Inc. |
NGAS powered self-resetting needle-less hypodermic jet injection apparatus and method
|
|
ES2443022T3
(es)
|
2005-08-12 |
2014-02-17 |
Merck Frosst Canada Inc. |
Derivados de indol como antagonistas del receptor CRTH2
|
|
JP4884570B2
(ja)
|
2008-08-20 |
2012-02-29 |
ファイザー・インク |
ピロロ［２，３−ｄ］ピリミジン化合物
|
|
AU2009295229B2
(en)
|
2008-09-22 |
2014-02-27 |
Merck Canada Inc. |
Indole derivatives as CRTH2 receptor antagonists
|
|
AU2009295231A1
(en)
|
2008-09-22 |
2010-03-25 |
Merck Canada Inc. |
Azaindole derivatives as CRTH2 receptor antagonists
|
|
WO2011075517A1
(en)
|
2009-12-17 |
2011-06-23 |
Merck Sharp & Dohme Corp. |
Aminopyrimidines as syk inhibitors
|
|
US8790651B2
(en)
|
2011-07-21 |
2014-07-29 |
Zoetis Llc |
Interleukin-31 monoclonal antibody
|
|
JP6701079B2
(ja)
|
2013-12-20 |
2020-05-27 |
インターベット インターナショナル ベー． フェー． |
ヒトｐｄ−１に対するイヌ化マウス抗体
|
|
WO2018073185A1
(en)
*
|
2016-10-17 |
2018-04-26 |
Vetoquinol Sa |
Modified antibody constant region
|
|
AU2017376398B2
(en)
|
2016-12-14 |
2021-07-15 |
Intervet International B.V. |
Aminopyrazoles as selective janus kinase inhibitors
|
|
WO2018156180A1
(en)
|
2017-02-24 |
2018-08-30 |
Kindred Biosciences, Inc. |
Anti-il31 antibodies for veterinary use
|
|
CN113227134A
(zh)
*
|
2018-12-05 |
2021-08-06 |
株式会社梅花治疗 |
抗体的Fc区变体
|
|
US11542333B2
(en)
*
|
2019-01-03 |
2023-01-03 |
Invetx, Inc. |
Compositions for increasing half-life of a therapeutic agent in canines and methods of use
|
|
CN110563844A
(zh)
*
|
2019-09-04 |
2019-12-13 |
华中农业大学 |
一种抗犬白介素31受体的多克隆抗体及其应用
|
|
MX2022007636A
(es)
*
|
2019-12-20 |
2022-07-19 |
Intervet Int Bv |
Anticuerpos biespecificos caninizados y pares de union biespecificos para el tratamiento contra dermatitis atopica.
|